AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Solventum Corporation
Video analysis: SOLV
All videosNo video analysis for this stock yet. Request one from our team.
News: SOLV
Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?
Solventum (SOLV) reported earnings 30 days ago. What's next for the stock?
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
EAGAN, Minn., Sept. 2, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, Sept.
Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?
Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.
Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Solventum Corporation (NYSE:SOLV) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Solventum Corporation (NYSE: SOLV - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen analysts that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and eight have issued a buy
Why Solventum (SOLV) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
SOLV Plans Health Information Systems Business Spinoff to Drive Growth
Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.
Similar companies
-
Encompass Health Corporation
EHC
·
New York Stock Exchange
Compare
-
The Ensign Group, Inc.
ENSG
·
NASDAQ
Compare
-
Universal Health Services, Inc.
UHS
·
New York Stock Exchange
Compare
-
Elanco Animal Health Incorporated
ELAN
·
New York Stock Exchange
Compare
-
Dr. Reddy's Laboratories Limited
RDY
·
New York Stock Exchange
Compare
-
Revvity, Inc.
RVTY
·
New York Stock Exchange
Compare